Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Kuwabara, Satoshi ^a   Dispenzieri, Angela ^b   Arimura, Kimiyoshi ^c   Misawa, Sonoko ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MAYO CLINIC   (United States)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN; LENALIDOMIDE; M PROTEIN; MELPHALAN; PREDNISONE; THALIDOMIDE; VASCULOTROPIN;

ABSENCE OF SIDE EFFECTS; ASCITES; CLINICAL FEATURE; CLINICAL TRIAL; COCHRANE LIBRARY; DEMYELINATION; DRUG ERUPTION; DRUG FATALITY; DRUG MEGADOSE; EMBASE; FATALITY; HUMAN; LEUKOPENIA; LONG TERM CARE; MEDLINE; MONOTHERAPY; MYELODYSPLASTIC SYNDROME; NEUROPATHY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PERIPHERAL NEUROPATHY; PLASMACYTOMA; PLASMAPHERESIS; PLEURA EFFUSION; POEMS SYNDROME; PROGNOSIS; QUALITY OF LIFE; RADIATION; REVIEW; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TRANSPLANTATION; TREATMENT OUTCOME;

EID: 55049099298     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006828.pub2     Document Type: Review

References (30)

1. Arimura 2007 Arimura K, Hashiguchi T. Crow-Fukase syndrome: Clinical features, pathogenesis and treatment in Japan. In: Yamamura T, Kira J, Tabira T editor(s). Current Topics in Neuroimmunology. Bologna, Italy: Medimond, 2007:241-5.
2. Badros 2005 Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 2005;106(3):1135.
3. Bardwick 1980 Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes: the POEMS syndrome. Report of two cases and a review of the literature. Medicine 1980;59(4):311-22.
4. Dispenzieri 2003 Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al.POEMS syndrome: definitions and long-term outcome. Blood 2003;101(7):2496-506.
5. Dispenzieri 2004 Dispenzieri A, Moreno-Aspitia A, Suarez GA, Lacy MQ, Colon-Otero G, Tefferi A, et al.Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004;104(10):3400-7.
6. Dispenzieri 2005a Dispenzieri A. POEMS Syndrome. Hematology American Society Hematology Education Program 2005;1:360-7.
7. Dispenzieri 2005b Dispenzieri A, Gertz MA. Treatment options for POEMS syndrome. Expert Opinion Pharmacotherapy 2005;6(6):945-53.
8. Dispenzieri 2007a Dispenzieri A. POEMS syndrome. Blood Reviews 2007;21(6):285-99.
9. Dispenzieri 2007b Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood 2007;110(3):1075-6.
10. Dispenzieri 2008 Dispenzieri A, Lacy MQ, Hayman SR, Kumar SK, Buadi F, Dingli D, et al.Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. European Journal of Haematology 2008;80(5):397-406.
11. Graham 2006 Graham RC, Hughes RA. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. Journal of Neurology, Neurosurgery, and Psychiatry 2006;77(8):973-6.
12. Hashiguchi 2000 Hashiguchi T, Arimura K, Matsumuro K, Otsuka R, Watanabe O, Jonosono M, et al.Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle & Nerve 2000; 23(7):1051-6.
13. Jaccard 2002 Jaccard A, Royer B, Bordessoule D, Brouet JC, Fermand JP. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood 2002;99(8):3057-9.
14. Kanai 2007 Kanai K, Kuwabara S, Misawa S, Hattori T. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Internal Medicine 2007;46(6):311-3.
15. Kim 2006 Kim SY, Lee SA, Ryoo HM, Lee KH, Hyun MS, Bae SH. Thalidomide for POEMS syndrome. Annals of Hematology 2006;85(8): 545-6.
16. Koike 2000 Koike H, Sobue G. Crow-Fukase syndrome. Neuropathology 2000; 20 Supplement:S69-72.
17. Kuwabara 1997 Kuwabara S, Hattori T, Shimoe Y, Kamitsukasa I. Long term melphalan-prednisolone chemotherapy for POEMS syndrome. Journal of Neurology, Neurosurgery, and Psychiatry 1997;63(3):385-7.
18. Kuwabara 2006 Kuwabara S, Misawa S, Kanai K, Kikkawa Y, Nishimura M, Nakaseko C, et al.Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 2006;66(1):105-7.
19. Kuwabara 2008a Kuwabara S, Misawa S, Kanai K, Kikkawa Y, Sawai S, Hattori T, et al.Neurological recovery after autologous peripheral blood stem cell transplantation in POEMS syndrome. Neurology 2008 (in press).
20. Kuwabara 2008b Kuwabara S, Misawa S, Kanai K, Sawai S, Hattori T, Nishimura M, et al.Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. Journal of Neurology, Neurosurgery, and Psychiatry 2008 (in press).
21. Nakanishi 1984 Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, et al.The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984;34(6):712-20.
22. Scarlato 2005 Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, et al.Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 2005;128(8):1911-20.
23. Sinisalo 2004 Sinisalo M, Hietaharju A, Sauranen J, Wirta O. Thalidomide in POEMS syndrome: case report. American Journal of Hematology 2004; 76(1):66-8.
24. Soubrier 1994 Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. The American Journal of Medicine 1994;97(6): 543-53.
25. Soubrier 1999 Soubrier M, Sauron C, Souweine B, Larroche C, Wechsler B, Guillevin L, et al.Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. American Journal of Kidney Diseases 1999;34(4):633-8.
26. Straume 2006 Straume O, Bergheim J, Ernst P. Bevacizumab therapy for POEMS syndrome. Blood 2006;107(12):4972-4.
27. Sung 2002 Sung JY, Kuwabara S, Ogawara K, Kanai K, Hattori T. Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle and Nerve 2002;26(2):189-93.
28. Vital 2003 Vital C, Vital A, Ferrer X, Viallard JF, Pellegrin JL, Bouillot S, et al.Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases. Journal of the Peripheral Nervous System 2003; 8(3):136-44.
29. Watanabe 1996 Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996;347(9002):702.
30. Watanabe 1998 Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, et al.Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle and Nerve 1998;21(11):1390-7.